Bora Pharmaceuticals Acquires Upsher-Smith Laboratories
August 5, 2025
Bora Pharmaceuticals completed a 2024 acquisition of Upsher-Smith Laboratories for $210 million and is expanding the Maple Grove, Minnesota manufacturing site with a multi-year buildout. The investment includes installation of a Gerteis Macro-Pactor (operational Q3 2025) and development of 100,000 square feet of shell space to boost oral solid dose (OSD) contract development and manufacturing capabilities.
- Buyers
- Bora Pharmaceuticals Co., Ltd.
- Targets
- Upsher-Smith Laboratories
- Industry
- Pharmaceuticals
- Location
- Minnesota, United States
- Transaction Type
- Buyout
Explore More
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.